Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AMIX Stock Forecast 2026-2027
$0.42
Current Price
$4.81M
Market Cap
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to AMIX Price Targets
+373.9%
To High Target of $2.00
+373.9%
To Median Target of $2.00
+373.9%
To Low Target of $2.00
AMIX Price Momentum
-2.3%
1 Week Change
+10.5%
1 Month Change
-79.5%
1 Year Change
-23.6%
Year-to-Date Change
-85.0%
From 52W High of $2.82
+23.4%
From 52W Low of $0.34
📊 TOP ANALYST CALLS
Did AMIX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Autonomix is one of their latest high-conviction picks.
Latest AMIX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, AMIX has a bullish consensus with a median price target of $2.00 (ranging from $2.00 to $2.00). The overall analyst rating is N/A (N/A/10). Currently trading at $0.42, the median forecast implies a 373.9% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Anthony Vendetti at Maxim Group, projecting a 373.9% upside. Conversely, the most conservative target is provided by Anthony Vendetti at Maxim Group, suggesting a 373.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AMIX Analyst Ratings
2
Buy
0
Hold
0
Sell
AMIX Price Target Range
Low
$2.00
Average
$2.00
High
$2.00
Current: $0.42
Latest AMIX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AMIX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 17, 2026 | Maxim Group | Anthony Vendetti | Buy | Maintains | $2.00 |
| Apr 29, 2025 | Maxim Group | Anthony Vendetti | Buy | Initiates | $5.00 |
| Sep 3, 2024 | Ladenburg Thalmann | Buy | Initiates | $1.40 |
Autonomix Medical Inc. (AMIX) Competitors
The following stocks are similar to Autonomix based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Autonomix Medical Inc. (AMIX) Financial Data
Autonomix Medical Inc. has a market capitalization of $4.81M with a P/E ratio of -0.1x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -188.7%.
Valuation Metrics
Market Cap
$4.81M
Enterprise Value
$-5,347,443
P/E Ratio
-0.1x
PEG Ratio
0.0x
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+206.4%
Current Ratio
6.2x
Debt/Equity
0.0x
ROE
-188.7%
ROA
-99.0%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Autonomix Medical Inc. (AMIX) Business Model
About Autonomix Medical Inc.
What They Do
Develops automated medical technology solutions.
Business Model
The company generates revenue by developing and commercializing automated systems that enhance the quality and efficiency of medical procedures. Their focus on sectors like minimally invasive surgery allows them to capitalize on the growing demand for improved patient outcomes and operational efficiency through advanced technology.
Additional Information
Autonomix Medical Inc. integrates robotics and software-driven platforms into healthcare, addressing global trends towards digital health and automated healthcare management. Their innovations aim to reduce human error and streamline surgical and diagnostic processes, positioning them as a key player in the evolving healthcare landscape.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
8
CEO
Mr. Bradley Hauser
Country
United States
IPO Year
2024
Website
autonomix.comAutonomix Medical Inc. (AMIX) Latest News & Analysis
Latest News
Autonomix Medical to Present at LSI USA '26
2 days ago
Quick Summary
Autonomix Medical, Inc. (NASDAQ: AMIX) will have CEO Brad Hauser present at LSI USA '26 on March 17, 2026, at 9:15 AM PT, focusing on precision nerve-targeted treatments.
Why It Matters
Brad Hauser's upcoming presentation at LSI USA '26 highlights Autonomix's focus on innovation in medical devices, potentially influencing investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Autonomix Medical, Inc. (NASDAQ: AMIX) will present clinical data on nerve-targeted treatments at the CRT 2026 Meeting from March 7-10, 2026, in Washington, DC.
Why It Matters
Autonomix Medical's presentation at a key medical conference could indicate advancements in their technology, potentially impacting stock performance and investor confidence in their growth prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Autonomix Medical, Inc. (NASDAQ: AMIX) announced its presentation on precision nerve-targeted treatments will be featured in the Best Innovation Competition at CRT 2026.
Why It Matters
Autonomix Medical's selection for a prestigious presentation highlights its innovation in medical technology, potentially boosting investor confidence and interest in its stock.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Autonomix Medical, Inc. (NASDAQ: AMIX) CEO Brad Hauser emphasized the importance of clinical credibility through rigorous science in a recent CEO Corner segment.
Why It Matters
Building clinical credibility through rigorous science enhances Autonomix Medical's reputation, potentially attracting investors and increasing stock value as it advances in the competitive medical device market.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Autonomix Medical, Inc. (NASDAQ: AMIX) will present new long-term clinical data at the SSO 2026 Annual Meeting on March 5-7, 2026, in Phoenix, Arizona.
Why It Matters
Presentation of long-term clinical data can signal advancements in product efficacy, potentially impacting stock performance and investor confidence in Autonomix Medical's future growth.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
New subgroup analysis indicates significant pain reduction in patients from Stage 2 to Stage 4 of disease, highlighting effectiveness in late-stage cases with few treatment options.
Why It Matters
The consistent pain reduction across all disease stages indicates potential for strong market demand and revenue growth for treatments targeting late-stage patients.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About AMIX Stock
What is Autonomix Medical Inc.'s (AMIX) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Autonomix Medical Inc. (AMIX) has a median price target of $2.00. The highest price target is $2.00 and the lowest is $2.00.
Is AMIX stock a good investment in 2026?
According to current analyst ratings, AMIX has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.42. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AMIX stock?
Wall Street analysts predict AMIX stock could reach $2.00 in the next 12 months. This represents a 373.9% increase from the current price of $0.42. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Autonomix Medical Inc.'s business model?
The company generates revenue by developing and commercializing automated systems that enhance the quality and efficiency of medical procedures. Their focus on sectors like minimally invasive surgery allows them to capitalize on the growing demand for improved patient outcomes and operational efficiency through advanced technology.
What is the highest forecasted price for AMIX Autonomix Medical Inc.?
The highest price target for AMIX is $2.00 from Anthony Vendetti at Maxim Group, which represents a 373.9% increase from the current price of $0.42.
What is the lowest forecasted price for AMIX Autonomix Medical Inc.?
The lowest price target for AMIX is $2.00 from Anthony Vendetti at Maxim Group, which represents a 373.9% increase from the current price of $0.42.
What is the overall AMIX consensus from analysts for Autonomix Medical Inc.?
The overall analyst consensus for AMIX is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $2.00.
How accurate are AMIX stock price projections?
Stock price projections, including those for Autonomix Medical Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: March 13, 2026 8:25 PM UTC